In re: CHROME HOLDING CO. (f/k/a 23ANDME HOLDING CO.), et al.

United States Bankruptcy Court, E.D. Missouri·Decided November 26, 2025·No. 25-40976·Unknown

Opinion

UNITED STATES BANKRUPTCY COURT EASTERN DISTRICT OF MISSOURI EASTERN DIVISION

In re: Case No. 25-40976-357 CHROME HOLDING CO. (f/k/a Chapter 11 23ANDME HOLDING CO.), et al., Jointly Administered Debtors.

MEMORANDUM OPINION Debtor ChromeCo, Inc., formerly known as 23andMe, Inc., sold its assets under Section 363 of the Bankruptcy Code earlier in this case. It then rejected its lease of a building in San Francisco owned by KR OP Tech, LLC (the “Landlord”). The Landlord filed a proof of claim for rejection damages of approximately $9.7 million. The Landlord has now objected to the Fourth Amended Joint Plan of Chrome Holding Co. and its Debtor Affiliates Pursuant to Chapter 11 of the Bankruptcy Code (the “Plan”). Its objections raise several issues, but all derive from a single fact: if Section 502(b)(6) of the Bankruptcy Code applies here, the Landlord’s allowed claim in this case will be limited to about $5.6 million.1 For the reasons discussed below, I will overrule the Landlord’s objections to confirmation of the Plan, but I will include language in the confirmation order protecting the Landlord’s rights against what may remain of the Debtor after confirmation. I. Jurisdiction The Court has subject-matter jurisdiction of the Debtor’s case and the plan- confirmation proceedings under 28 U.S.C. § 1334(a)-(b). This is a core proceeding under 28 U.S.C. § 157(b)(2)(L).

1 The Debtor has not agreed to either of these calculations, but it has not disputed them for purposes of the legal issues raised by the Landlord. I will take the same approach. II. Background A. The Debtors’ Business and History Before filing for bankruptcy relief, the Debtors in these cases operated a direct-to- consumer genetic-testing business.2 Customers could send the company saliva samples in exchange for extensive information about their personal genomes, including ancestry and susceptibility to certain illnesses. In operating this business, the Debtors stored highly sensitive personal information, including saliva samples, DNA testing results, and other customer information such as names and email addresses. In 2023, the company announced that it had suffered a data breach, during which hackers accessed the personal data of approximately seven million customers. Extensive litigation and threats of legal action ensued after the data breach. The fallout from the data breach strained the Debtors’ resources and, along with other economic factors, led the Debtors to file for Chapter 11 relief. In March 2025, the Debtors filed a motion to establish bidding procedures and to set certain deadlines for the sale of their assets, and I granted that motion. A lengthy sale process followed, culminating in a two-day evidentiary hearing on the Debtors’ motion to sell substantially all of their assets, except the Lemonaid telehealth business, for a purchase price of $302.5 million. I entered an order approving the sale on June 27, 2025, and the sale closed on July 14, 2025. See In re 23andMe Holding Co., --- B.R. ----, 2025 WL 1791166 (Bankr. E.D. Mo. June 27, 2025). The Debtors filed their original Chapter 11 plan and disclosure statement on August 15, 2025. I entered an order approving the adequacy of the disclosure statement and the confirmation procedures on October 1, 2025. The Debtors have since filed various supplements and amended plans, with the most recent being the Plan. On September 11, 2025, the Debtors filed a Notice of Lemonaid Stock Purchase Agreement, which indicated an intent to consummate the sale of the Lemonaid telehealth business through the Plan. Pursuant to this agreement, Bambumeta Ventures, LLC will acquire 100% of the outstanding capital stock of Debtors Lemonaid Health, Inc. and Chrome Pharmacy Holdings, and thus obtain indirect ownership of several other subsidiaries (collectively, the “Lemonaid Debtors”) for $10 million. No party objected to the related plan

Free access — add to your briefcase to read the full text and ask questions with AI

In re: CHROME HOLDING CO. (f/k/a 23ANDME HOLDING CO.), et al., (Mo. 2025).

In re: CHROME HOLDING CO. (f/k/a 23ANDME HOLDING CO.), et al. (In re: CHROME HOLDING CO. (f/k/a 23ANDME HOLDING CO.), et al.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Zavelo v. Reeves
227 U.S. 625 (Supreme Court, 1913)
City Bank Farmers Trust Co. v. Irving Trust Co.
299 U.S. 433 (Supreme Court, 1937)
Kuehner v. Irving Trust Co.
299 U.S. 445 (Supreme Court, 1937)
United States v. Noland
517 U.S. 535 (Supreme Court, 1996)
Cohen v. De La Cruz
523 U.S. 213 (Supreme Court, 1998)
Oldden v. Tonto Realty Corporation
143 F.2d 916 (Second Circuit, 1944)
Kuhner v. Irving Trust Co.
85 F.2d 35 (Second Circuit, 1936)
In Re Farley, Inc.
146 B.R. 739 (N.D. Illinois, 1992)
1500 Mineral Spring Associates, LP v. Gencarelli
353 B.R. 771 (D. Rhode Island, 2006)
In Re PPI Enterprises (U.S.), Inc.
228 B.R. 339 (D. Delaware, 1998)
In Re Dow Corning Corp.
237 B.R. 380 (E.D. Michigan, 1999)
In Re Liberate Technologies
314 B.R. 206 (N.D. California, 2004)
Matter of Interco Inc.
137 B.R. 1003 (E.D. Missouri, 1992)
Goodnow v. Adelman (In Re Adelman)
90 B.R. 1012 (D. South Dakota, 1988)
In Re American Solar King Corp.
90 B.R. 808 (W.D. Texas, 1988)
In Re Introgen Therapeutics, Inc.
429 B.R. 570 (W.D. Texas, 2010)
Computer Task Group, Inc. v. Brotby (In Re Brotby)
303 B.R. 177 (Ninth Circuit, 2003)
In Re Danrik, Ltd.
92 B.R. 964 (N.D. Georgia, 1988)